Global Anti-tumor Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Anti-tumor Drug by Type
  • 1.3.1 Overview: Global Anti-tumor Drug Market Size by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Global Anti-tumor Drug Consumption Value Market Share by Type in 2024
  • 1.3.3 Cytotoxic Drugs
  • 1.3.4 Non-cytotoxic Drugs
• 1.4 Global Anti-tumor Drug Market by Application
  • 1.4.1 Overview: Global Anti-tumor Drug Market Size by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Alkylating Agents
  • 1.4.3 Anti-Metabolism Drugs
  • 1.4.4 Platinum Antineoplastic Agents
  • 1.4.5 Anthracycline Antitumor Drugs
  • 1.4.6 Microtubule Stabilizer
  • 1.4.7 Endocrine Therapy Drugs
  • 1.4.8 Immunotherapy Drugs
  • 1.4.9 Gene Therapy Drugs
  • 1.4.10 Targeted Antineoplastic Drugs
• 1.5 Global Anti-tumor Drug Market Size & Forecast
• 1.6 Global Anti-tumor Drug Market Size and Forecast by Region
  • 1.6.1 Global Anti-tumor Drug Market Size by Region: 2020 VS 2024 VS 2031
  • 1.6.2 Global Anti-tumor Drug Market Size by Region, (2020-2031)
  • 1.6.3 North America Anti-tumor Drug Market Size and Prospect (2020-2031)
  • 1.6.4 Europe Anti-tumor Drug Market Size and Prospect (2020-2031)
  • 1.6.5 Asia-Pacific Anti-tumor Drug Market Size and Prospect (2020-2031)
  • 1.6.6 South America Anti-tumor Drug Market Size and Prospect (2020-2031)
  • 1.6.7 Middle East & Africa Anti-tumor Drug Market Size and Prospect (2020-2031)

2 Company Profiles

• 2.1 Roche
  • 2.1.1 Roche Details
  • 2.1.2 Roche Major Business
  • 2.1.3 Roche Anti-tumor Drug Product and Solutions
  • 2.1.4 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Roche Recent Developments and Future Plans
• 2.2 Novartis
  • 2.2.1 Novartis Details
  • 2.2.2 Novartis Major Business
  • 2.2.3 Novartis Anti-tumor Drug Product and Solutions
  • 2.2.4 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Novartis Recent Developments and Future Plans
• 2.3 Celgene
  • 2.3.1 Celgene Details
  • 2.3.2 Celgene Major Business
  • 2.3.3 Celgene Anti-tumor Drug Product and Solutions
  • 2.3.4 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Celgene Recent Developments and Future Plans
• 2.4 Bristol-Myers Squibb
  • 2.4.1 Bristol-Myers Squibb Details
  • 2.4.2 Bristol-Myers Squibb Major Business
  • 2.4.3 Bristol-Myers Squibb Anti-tumor Drug Product and Solutions
  • 2.4.4 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
• 2.5 Amgen
  • 2.5.1 Amgen Details
  • 2.5.2 Amgen Major Business
  • 2.5.3 Amgen Anti-tumor Drug Product and Solutions
  • 2.5.4 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 Amgen Recent Developments and Future Plans
• 2.6 Johnson & Johnson
  • 2.6.1 Johnson & Johnson Details
  • 2.6.2 Johnson & Johnson Major Business
  • 2.6.3 Johnson & Johnson Anti-tumor Drug Product and Solutions
  • 2.6.4 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Johnson & Johnson Recent Developments and Future Plans
• 2.7 Pfizer
  • 2.7.1 Pfizer Details
  • 2.7.2 Pfizer Major Business
  • 2.7.3 Pfizer Anti-tumor Drug Product and Solutions
  • 2.7.4 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Pfizer Recent Developments and Future Plans
• 2.8 Takeda
  • 2.8.1 Takeda Details
  • 2.8.2 Takeda Major Business
  • 2.8.3 Takeda Anti-tumor Drug Product and Solutions
  • 2.8.4 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Takeda Recent Developments and Future Plans
• 2.9 Eli Lilly
  • 2.9.1 Eli Lilly Details
  • 2.9.2 Eli Lilly Major Business
  • 2.9.3 Eli Lilly Anti-tumor Drug Product and Solutions
  • 2.9.4 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 Eli Lilly Recent Developments and Future Plans
• 2.10 AstraZeneca
  • 2.10.1 AstraZeneca Details
  • 2.10.2 AstraZeneca Major Business
  • 2.10.3 AstraZeneca Anti-tumor Drug Product and Solutions
  • 2.10.4 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 AstraZeneca Recent Developments and Future Plans
• 2.11 Astellas
  • 2.11.1 Astellas Details
  • 2.11.2 Astellas Major Business
  • 2.11.3 Astellas Anti-tumor Drug Product and Solutions
  • 2.11.4 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 Astellas Recent Developments and Future Plans
• 2.12 Merck & Co
  • 2.12.1 Merck & Co Details
  • 2.12.2 Merck & Co Major Business
  • 2.12.3 Merck & Co Anti-tumor Drug Product and Solutions
  • 2.12.4 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.12.5 Merck & Co Recent Developments and Future Plans
• 2.13 Sanofi
  • 2.13.1 Sanofi Details
  • 2.13.2 Sanofi Major Business
  • 2.13.3 Sanofi Anti-tumor Drug Product and Solutions
  • 2.13.4 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.13.5 Sanofi Recent Developments and Future Plans
• 2.14 Bayer
  • 2.14.1 Bayer Details
  • 2.14.2 Bayer Major Business
  • 2.14.3 Bayer Anti-tumor Drug Product and Solutions
  • 2.14.4 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.14.5 Bayer Recent Developments and Future Plans
• 2.15 Biogen Idec
  • 2.15.1 Biogen Idec Details
  • 2.15.2 Biogen Idec Major Business
  • 2.15.3 Biogen Idec Anti-tumor Drug Product and Solutions
  • 2.15.4 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.15.5 Biogen Idec Recent Developments and Future Plans
• 2.16 Eisai
  • 2.16.1 Eisai Details
  • 2.16.2 Eisai Major Business
  • 2.16.3 Eisai Anti-tumor Drug Product and Solutions
  • 2.16.4 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.16.5 Eisai Recent Developments and Future Plans
• 2.17 Teva
  • 2.17.1 Teva Details
  • 2.17.2 Teva Major Business
  • 2.17.3 Teva Anti-tumor Drug Product and Solutions
  • 2.17.4 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.17.5 Teva Recent Developments and Future Plans
• 2.18 Otsuka
  • 2.18.1 Otsuka Details
  • 2.18.2 Otsuka Major Business
  • 2.18.3 Otsuka Anti-tumor Drug Product and Solutions
  • 2.18.4 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
  • 2.18.5 Otsuka Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Anti-tumor Drug Revenue and Share by Players (2020-2025)
• 3.2 Market Share Analysis (2024)
  • 3.2.1 Market Share of Anti-tumor Drug by Company Revenue
  • 3.2.2 Top 3 Anti-tumor Drug Players Market Share in 2024
  • 3.2.3 Top 6 Anti-tumor Drug Players Market Share in 2024
• 3.3 Anti-tumor Drug Market: Overall Company Footprint Analysis
  • 3.3.1 Anti-tumor Drug Market: Region Footprint
  • 3.3.2 Anti-tumor Drug Market: Company Product Type Footprint
  • 3.3.3 Anti-tumor Drug Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Anti-tumor Drug Consumption Value and Market Share by Type (2020-2025)
• 4.2 Global Anti-tumor Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

• 5.1 Global Anti-tumor Drug Consumption Value Market Share by Application (2020-2025)
• 5.2 Global Anti-tumor Drug Market Forecast by Application (2026-2031)

6 North America

• 6.1 North America Anti-tumor Drug Consumption Value by Type (2020-2031)
• 6.2 North America Anti-tumor Drug Market Size by Application (2020-2031)
• 6.3 North America Anti-tumor Drug Market Size by Country
  • 6.3.1 North America Anti-tumor Drug Consumption Value by Country (2020-2031)
  • 6.3.2 United States Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 6.3.3 Canada Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 6.3.4 Mexico Anti-tumor Drug Market Size and Forecast (2020-2031)

7 Europe

• 7.1 Europe Anti-tumor Drug Consumption Value by Type (2020-2031)
• 7.2 Europe Anti-tumor Drug Consumption Value by Application (2020-2031)
• 7.3 Europe Anti-tumor Drug Market Size by Country
  • 7.3.1 Europe Anti-tumor Drug Consumption Value by Country (2020-2031)
  • 7.3.2 Germany Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 7.3.3 France Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 7.3.4 United Kingdom Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 7.3.5 Russia Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 7.3.6 Italy Anti-tumor Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific

• 8.1 Asia-Pacific Anti-tumor Drug Consumption Value by Type (2020-2031)
• 8.2 Asia-Pacific Anti-tumor Drug Consumption Value by Application (2020-2031)
• 8.3 Asia-Pacific Anti-tumor Drug Market Size by Region
  • 8.3.1 Asia-Pacific Anti-tumor Drug Consumption Value by Region (2020-2031)
  • 8.3.2 China Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 8.3.3 Japan Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 8.3.4 South Korea Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 8.3.5 India Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 8.3.6 Southeast Asia Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 8.3.7 Australia Anti-tumor Drug Market Size and Forecast (2020-2031)

9 South America

• 9.1 South America Anti-tumor Drug Consumption Value by Type (2020-2031)
• 9.2 South America Anti-tumor Drug Consumption Value by Application (2020-2031)
• 9.3 South America Anti-tumor Drug Market Size by Country
  • 9.3.1 South America Anti-tumor Drug Consumption Value by Country (2020-2031)
  • 9.3.2 Brazil Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 9.3.3 Argentina Anti-tumor Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa

• 10.1 Middle East & Africa Anti-tumor Drug Consumption Value by Type (2020-2031)
• 10.2 Middle East & Africa Anti-tumor Drug Consumption Value by Application (2020-2031)
• 10.3 Middle East & Africa Anti-tumor Drug Market Size by Country
  • 10.3.1 Middle East & Africa Anti-tumor Drug Consumption Value by Country (2020-2031)
  • 10.3.2 Turkey Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 10.3.3 Saudi Arabia Anti-tumor Drug Market Size and Forecast (2020-2031)
  • 10.3.4 UAE Anti-tumor Drug Market Size and Forecast (2020-2031)

11 Market Dynamics

• 11.1 Anti-tumor Drug Market Drivers
• 11.2 Anti-tumor Drug Market Restraints
• 11.3 Anti-tumor Drug Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Anti-tumor Drug Industry Chain
• 12.2 Anti-tumor Drug Upstream Analysis
• 12.3 Anti-tumor Drug Midstream Analysis
• 12.4 Anti-tumor Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source